Home / Pharmaceutical company intelligence
Sigma Pharma International (Pvt.) Ltd. logo
Pharmaceutical company intelligence

Sigma Pharma International products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Karachi · Pakistan

Karachi-based pharmaceutical manufacturer founded in 2006 with a diversified portfolio across anti-infective, analgesic, gastrointestinal, antiallergic and nutraceutical categories.

Sigma Pharma International products in Pakistan

Sigma Pharma International (Pvt.) Ltd has 101 medicine presentations registered in Pakistan under 41 brands, covering 36 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Stipen (Quetiapine), Cesh (Ceftriaxone), Letres (Levetiracetam) and Loud (Clarithromycin). 101 products have an official DRAP price on MedInfoBase. See all 41 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check12 Oct 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Private pharmaceutical manufacturer
Address
46-E/3, Block 6, P.E.C.H.S., Karachi, Pakistan
Phone
+92 21 34390461-4; +92 21 34154376
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000804 Sigma Pharma International (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000804 101 linked products · source seen 11 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx103public portfolio records represented
REG83unique registrations represented
IDX101indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+2registry-only registrations
VER30registry-verified exact registrations
PKR101current validated price records
G36generic molecules in indexed catalogue
DF9dosage-form groups
TA9therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage98%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage96%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixSigma Pharma International (Pvt.) Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/sigma-pharma-international-pvt-ltdGenerated 11 Nov 2026Anti-infectives55 · 54%CNS & mental health30 · 30%Gastrointestinal & hepatology5 · 5%Cardiovascular3 · 3%Vitamins, minerals & nutrition3 · 3%Reproductive & genitourinary2 · 2%Dermatology1 · 1%Other therapeutic areas2 · 2%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioSigma Pharma International (Pvt.) Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/sigma-pharma-international-pvt-ltdGenerated 11 Nov 2026101presentationsTablet62 · 61%Injection10 · 10%Suspension9 · 9%Capsule8 · 8%Cream4 · 4%Sachet3 · 3%Other forms5 · 5%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionSigma Pharma International (Pvt.) Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/sigma-pharma-international-pvt-ltdGenerated 11 Nov 202697comparable productsBelow peer median19 · 20%Near peer median54 · 56%Above peer median24 · 25%Company median price position+0.0%Lowest-price equivalents1Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsSigma Pharma International (Pvt.) Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/sigma-pharma-international-pvt-ltdGenerated 11 Nov 2026Nabiqasim Industries (Pvt) Ltd.,30 shared83% overlapM/s. Genix Pharma (Pvt) Ltd.25 shared69% overlapValor Pharmaceuticals25 shared69% overlapNeutro Pharma (Pvt.) Ltd.,25 shared69% overlapGenome Pharmaceuticals (Pvt.) Ltd.25 shared69% overlapHIGH-Q Pharmaceuticals24 shared67% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet62 products
Injection10 products
Suspension9 products
Capsule8 products
Cream4 products
Sachet3 products
Infusion2 products
Ointment2 products
Gel1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Sigma Pharma International (Pvt.) Ltd. is priced against the market

97 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers81Distinct registrations among indexed, published, presentation-validated products only
Verified price observations101
Products with a verified price101
Products with multiple price observations0
Source records with multiple versions101
Latest portfolio source check12 Oct 2026
Latest effective price date27 Jul 2026
Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

83 unique registration(s) · 101 indexed presentation(s) · 2 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Acnebact Benzoyl peroxide 40 mg/g Cream 40gm 079909 PKR 227.93 PKR 5.70/g 🔒 Pharma Pro
Amdova Amlodipine 2.5 mg Tablet 20's 104489 PKR 110.35 PKR 5.52/tablet 🔒 Pharma Pro
Amdova Amlodipine 5 mg Tablet 20's 104490 PKR 216.87 PKR 10.84/tablet 🔒 Pharma Pro
Amdova Amlodipine 10 mg Tablet 20's 104491 PKR 309.24 PKR 15.46/tablet 🔒 Pharma Pro
Antif /g Clotrimazole 10 mg Cream 15gm 079913 PKR 89.31 PKR 5.95/g 🔒 Pharma Pro
Burnaid /g Silver sulfadiazine 10 mg/g Cream 50gm 079908 PKR 180.85 PKR 3.62/g 🔒 Pharma Pro
Cesh Ceftriaxone 250 mg IV injection 1's 101217 PKR 196.09 PKR 196.09/vial/unit 🔒 Pharma Pro
Cesh Ceftriaxone 500 mg IV injection 1's 101218 PKR 330.05 PKR 330.05/vial/unit 🔒 Pharma Pro
Cesh Ceftriaxone 1 g IV injection 1's 101219 PKR 623.22 PKR 623.22/vial/unit 🔒 Pharma Pro
Cesh Ceftriaxone 250 mg IM injection 1's 101220 PKR 196.09 PKR 196.09/vial/unit 🔒 Pharma Pro
Cesh Ceftriaxone 500 mg IM injection 1's 101221 PKR 330.05 PKR 330.05/vial/unit 🔒 Pharma Pro
Cesh Ceftriaxone 1 g IM injection 1's 101222 PKR 623.22 PKR 623.22/vial/unit 🔒 Pharma Pro
Civolt Ascorbic acid 500 mg Chewable tablet 40's 107672 PKR 80.22 PKR 2.01/tablet 🔒 Pharma Pro
Civolt Effervescent Ascorbic acid 1 g Tablet 10's 107673 PKR 97.29 PKR 9.73/tablet No comparator
Delep Capsule 60mgRegistry verified Dexlansoprazole Dual Delayed Release Pellets Eq. to Dexlansoprazole — — — 123436Official source ↗ No indexed price — —
Delep Capsules 30mgRegistry verified DEXLANSOPRAZOLE — — — 128072Official source ↗ No indexed price — —
Doxy Doxycycline 100 mg Capsule 50's 086833 PKR 388.30 PKR 7.77/capsule 🔒 Pharma Pro
Doxy Doxycycline 100 mg Capsule 100's 086833 PKR 757.18 PKR 7.57/capsule 🔒 Pharma Pro
Fleelax Risperidone 1 mg Tablet 10's 090798 PKR 232.97 PKR 23.30/tablet 🔒 Pharma Pro
Fleelax Risperidone 2 mg Tablet 10's 090799 PKR 378.60 PKR 37.86/tablet 🔒 Pharma Pro
Fleelax Risperidone 3 mg Tablet 10's 090800 PKR 582.44 PKR 58.24/tablet 🔒 Pharma Pro
Fleelax Risperidone 4 mg Tablet 10's 090801 PKR 757.18 PKR 75.72/tablet 🔒 Pharma Pro
Flisk Fluconazole 150 mg Capsule 1's 076728 PKR 267.93 PKR 267.93/capsule 🔒 Pharma Pro
Flisk Fluconazole 50 mg/5 mL Dry suspension 35ml 076739 PKR 416.25 PKR 11.89/mL 🔒 Pharma Pro
Irodela FA Folic acid 100 mg Tablet 30's 112580 PKR 467.78 PKR 15.59/tablet 🔒 Pharma Pro
Letres Levetiracetam 250 mg Tablet 30's 098507 PKR 1,779.02 PKR 59.30/tablet 🔒 Pharma Pro
Letres Levetiracetam 250 mg Tablet 10's 098507 PKR 592.25 PKR 59.23/tablet 🔒 Pharma Pro
Letres Levetiracetam 500 mg Tablet 30's 098508 PKR 2,949.98 PKR 98.33/tablet 🔒 Pharma Pro
Letres Levetiracetam 500 mg Tablet 10's 098508 PKR 983.32 PKR 98.33/tablet 🔒 Pharma Pro
Letres Levetiracetam 750 mg Tablet 30's 098509 PKR 3,933.29 PKR 131.11/tablet 🔒 Pharma Pro
Letres Levetiracetam 750 mg Tablet 10's 098509 PKR 1,311.08 PKR 131.11/tablet 🔒 Pharma Pro
Letres XR Levetiracetam 500 mg Extended-release tablet 10's 098510 PKR 1,080.52 PKR 108.05/tablet 🔒 Pharma Pro
Linzyle Linezolid 100 mg/5 mL Dry suspension 60ml 076740 PKR 679.52 PKR 11.33/mL 🔒 Pharma Pro
Linzyle Linezolid 400 mg Tablet 12's 102946 PKR 2,834.59 PKR 236.22/tablet 🔒 Pharma Pro
Linzyle Linezolid 600 mg Tablet 12's 102947 PKR 4,962.47 PKR 413.54/tablet 🔒 Pharma Pro
Livcavir Entecavir 0.5 mg Tablet 30's 112708 PKR 9,827.87 PKR 327.60/tablet 🔒 Pharma Pro
Livcavir Entecavir 0.5 mg Tablet 10's 112708 PKR 3,560.53 PKR 356.05/tablet 🔒 Pharma Pro
Livcavir Entecavir 0.5 mg Tablet 14's 112708 PKR 4,986.74 PKR 356.20/tablet 🔒 Pharma Pro
Livcavir Entecavir 0.5 mg Tablet 20's 112708 PKR 6,764.01 PKR 338.20/tablet 🔒 Pharma Pro
Loud Clarithromycin 250 mg Tablet 10's 076715 PKR 475.71 PKR 47.57/tablet 🔒 Pharma Pro
Loud Clarithromycin 500 mg Tablet 10's 076716 PKR 776.60 PKR 77.66/tablet 🔒 Pharma Pro
Loud Clarithromycin 125 mg/5 mL Dry suspension 60ml 076734 PKR 442.01 PKR 7.37/mL 🔒 Pharma Pro
Loud Clarithromycin 125 mg/5 mL Dry suspension 30ml 076734 PKR 218.03 PKR 7.27/mL 🔒 Pharma Pro
Loud Clarithromycin 250 mg/5 mL Dry suspension 60ml 076735 PKR 731.40 PKR 12.19/mL 🔒 Pharma Pro
Loud XL Clarithromycin 500 mg Extended-release tablet 1×5's 090947 PKR 401.89 PKR 80.38/tablet 🔒 Pharma Pro
Lymbda Lamivudine 100 mg Tablet 14's 088934 PKR 792.85 PKR 56.63/tablet 🔒 Pharma Pro
Malisq Hydroxychloroquine 200 mg Tablet 30's 095995 PKR 524.20 PKR 17.47/tablet 🔒 Pharma Pro
Mizzi Misoprostol 200 mcg Tablet 28's 105394 PKR 586.30 PKR 20.94/tablet 🔒 Pharma Pro
Mizzi Misoprostol 200 mcg Tablet 10's 105394 PKR 209.41 PKR 20.94/tablet 🔒 Pharma Pro
Mogel 20mg/g Oral Miconazole 20 mg/g Gel 20gm 079910 PKR 168.48 PKR 8.42/g 🔒 Pharma Pro
A to Z

All 41 Sigma Pharma International brands in Pakistan

  • Acnebact Benzoyl peroxide · 40 mg/g cream
  • Amdova Amlodipine · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
  • Antif /g Clotrimazole · 10 mg cream
  • Burnaid /g Silver sulfadiazine · 10 mg/g cream
  • Cesh Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
  • Civolt Ascorbic acid · 500 mg tablet
  • Civolt Effervescent Ascorbic acid · 1 g tablet
  • Doxy Doxycycline · 100 mg capsule
  • Fleelax Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
  • Flisk Fluconazole · 150 mg capsule, 50 mg/5 mL suspension
  • Irodela FA Folic acid · 100 mg tablet
  • Letres Levetiracetam · 250 mg tablet, 500 mg tablet, 750 mg tablet
  • Letres XR Levetiracetam · 500 mg tablet
  • Linzyle Linezolid · 100 mg/5 mL suspension, 400 mg tablet, 600 mg tablet
  • Livcavir Entecavir · 0.5 mg tablet
  • Loud Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
  • Loud XL Clarithromycin · 500 mg tablet
  • Lymbda Lamivudine · 100 mg tablet
  • Malisq Hydroxychloroquine · 200 mg tablet
  • Mizzi Misoprostol · 200 mcg tablet
  • Mogel 20mg/g Oral Miconazole · 20 mg/g gel
  • Motingo Lamotrigine = · 100 mg tablet, 25 mg tablet, 50 mg tablet
  • Mupe 20mg/g Mupirocin · 20 mg ointment
  • Oralite Sodium chloride · 2.6 g sachet
  • Paracetra Paracetamol · 500 mg tablet
  • Promep Omeprazole, Omeprazole + Sodium bicarbonate · 20 mg sachet, 20 mg capsule, 40 mg infusion
  • Rotrif Artemether + Lumefantrine · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet, 80 mg + 480 mg tablet
  • Rotrif 80/480mg Artemether + Lumefantrine · 80 mg + 480 mg tablet
  • Sigval Divalproex sodium · 250 mg tablet, 500 mg tablet
  • Smitri Sumatriptan · 50 mg tablet
  • Sotay Cefotaxime · 1 g injection, 2 g injection, 250 mg injection
  • Stipen Quetiapine · 100 mg tablet, 200 mg tablet, 25 mg tablet
  • Tofir Tenofovir disoproxil · 300 mg tablet, 300 mg (equiv. 245 mg tenofovir disoproxil) tablet
  • Torpiz Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 200 mg/5 mL suspension
  • Tweet Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg tablet
  • Twig Moxifloxacin · 400 mg tablet
  • Veloft Levofloxacin · 250 mg tablet
  • Veloft DS Levofloxacin · 500 mg tablet
  • Vift Ciprofloxacin · 200 mg/100 mL infusion, 250 mg tablet, 500 mg tablet
  • Voclir Aciclovir · 50 mg/g (5%) ointment
  • Voclir w/w Aciclovir · 5 % cream
Questions

Sigma Pharma International: common questions

How many products does Sigma Pharma International have in Pakistan?

Sigma Pharma International (Pvt.) Ltd has 101 registered medicine presentations in Pakistan, sold under 41 brands and covering 36 generic medicines.

What are the main brands of Sigma Pharma International?

By number of registered strengths and packs, its largest brands are Stipen (Quetiapine), Cesh (Ceftriaxone), Letres (Levetiracetam), Loud (Clarithromycin) and Promep (Omeprazole, Omeprazole + Sodium bicarbonate). This is not a sales ranking.

Which therapy areas does Sigma Pharma International cover?

The most products are in Anti-infectives (54), CNS & mental health (30), Gastrointestinal & hepatology (5), Cardiovascular (3) and Vitamins, minerals & nutrition (3).

Where can I see Sigma Pharma International medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Sigma Pharma International (Pvt.) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/sigma-pharma-international-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9